NEWS

Dr. Carlos Guijarro in the Consensus of the Spanish Society of Arteriosclerosis

Posted by miguel lamb

Dr. Carlos Guijarro has participated in the new Consensus of the Spanish Society of Arteriosclerosis for the recommendations of a new group of drugs: proprotein convertase subtilisin kexin 9 (iPCSK9) inhibitors, recently published and disseminated on the net, noting its affiliation to the Fundacion Alcorcon University Hospital and the Department of Medicine of the Faculty of Health Sciences of the Rey Juan Carlos University. 

Dr. Carlos Guijarro in the Consensus of the Spanish Society of Arteriosclerosis

You will find all the information in the following links:

https://www.redtrescero.es/es/recomendaciones-sea

https://www.sciencedirect.com/science/article/pii/S0214916819300518?via%3Dihub

Tagged
More in this section: « Pharmacy: new degree in the FCS Research Scholarship Award to Mr. Juan Francisco Peña Cardelles »
Go up